Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23813356 | 0.82 | BTN3A1 (0.31) | RIPK1 | |
| SCHEMBL23843973 | 0.78 | BTN3A1 (0.37) | RIPK1 | |
| SCHEMBL23844141 | 0.77 | BTN3A1 (0.36) | RIPK1 | |
| SCHEMBL23034485 | 0.77 | BTN3A1 (0.38) | RIPK1 | |
| SCHEMBL22143099 | 0.76 | BTN3A1 (0.34) | RIPK1 | |
| SCHEMBL25012702 | 0.76 | BTN3A1 (0.33) | — | |
| SCHEMBL24699894 | 0.76 | RIPK1 (0.33) | RIPK1 | |
| SCHEMBL23034575 | 0.74 | HPRT1 (0.37) | RIPK1 | |
| SCHEMBL25511597 | 0.74 | BTN3A1 (0.35) | RIPK1 | |
| SCHEMBL20078704 | 0.74 | BTN3A1 (0.35) | RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025873-A1 | METHOD FOR PRODUCING KETONE DERIVATIVE | TOKUYAMA CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025873-A1 | METHOD FOR PRODUCING KETONE DERIVATIVE | HSD17B7, BCKDK, KARS1 | RIPK1 2718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.